Phibro Animal Health Announces Quarterly Dividend of $0.12 per Share
ByAinvest
Tuesday, Jul 29, 2025 4:13 pm ET1min read
PAHC--
Phibro Animal Health Corporation is a leading global diversified animal health and nutrition company. It provides essential animal health solutions and mineral nutrition products for global food production systems. The company's latest dividend declaration is a reflection of its robust financial health and growth trajectory.
In the latest quarterly report, PAHC reported strong financial results, with net sales increasing by 32% to $347.8 million and net income rising to $20.9 million. The company's performance was driven by the successful integration of the Zoetis MFA business and Phibro Forward initiatives. The Animal Health segment grew by 42%, with MFA & Other product sales up by 68%.
The company maintains a strong balance sheet with a gross leverage ratio of 3.0x and $70.4 million in cash and short-term investments. The updated FY2025 guidance projects net sales of $1.26-1.29 billion and adjusted EBITDA of $177-183 million.
Phibro Animal Health Corporation's dividend declaration is a testament to its financial stability and commitment to shareholders. The company continues to expand its reach and provide innovative solutions to maintain and enhance the health of animals.
References:
[1] https://www.stocktitan.net/news/PAHC/phibro-animal-health-corporation-declares-quarterly-7ewl7bllpydo.html
[2] https://www.marketscreener.com/news/phibro-animal-health-corporation-declares-quarterly-dividend-ce7c5fdeda8ef622
ZTS--
Phibro Animal Health Corporation declared a quarterly cash dividend of $0.12 per share on its Class A and Class B common stock. The dividend is payable on September 24, 2025, to stockholders of record at the close of business on September 3, 2025. The company is a global diversified animal health and nutrition company that strives to be a trusted partner with livestock producers and veterinarians.
Phibro Animal Health Corporation (PAHC) has announced a quarterly cash dividend of $0.12 per share on its Class A and Class B common stock. The dividend will be payable on September 24, 2025, to stockholders of record at the close of business on September 3, 2025. This declaration follows the company's strong financial performance and continues its commitment to shareholder value.Phibro Animal Health Corporation is a leading global diversified animal health and nutrition company. It provides essential animal health solutions and mineral nutrition products for global food production systems. The company's latest dividend declaration is a reflection of its robust financial health and growth trajectory.
In the latest quarterly report, PAHC reported strong financial results, with net sales increasing by 32% to $347.8 million and net income rising to $20.9 million. The company's performance was driven by the successful integration of the Zoetis MFA business and Phibro Forward initiatives. The Animal Health segment grew by 42%, with MFA & Other product sales up by 68%.
The company maintains a strong balance sheet with a gross leverage ratio of 3.0x and $70.4 million in cash and short-term investments. The updated FY2025 guidance projects net sales of $1.26-1.29 billion and adjusted EBITDA of $177-183 million.
Phibro Animal Health Corporation's dividend declaration is a testament to its financial stability and commitment to shareholders. The company continues to expand its reach and provide innovative solutions to maintain and enhance the health of animals.
References:
[1] https://www.stocktitan.net/news/PAHC/phibro-animal-health-corporation-declares-quarterly-7ewl7bllpydo.html
[2] https://www.marketscreener.com/news/phibro-animal-health-corporation-declares-quarterly-dividend-ce7c5fdeda8ef622

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet